Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
AstronauTx secures investment from UCL Technology Fund to further new approaches to dementia therapeutics
Quadruplex-binding compounds – a novel anticancer strategy
We have a first-in-class optimized small-molecule drug candidate ready for IND enabling studies with superior efficacy and activity against pancreatic cancer compared to existing agents, together with a distinct mechanism of action.
How does Portico Ventures support non-patentable and fast-to-deploy technologies?
The following interview took place in April 2019 towards the end of the one-year pilot phase of Portico Ventures. Following positive feedback from the Department of Computer Science where the pilot ran, Portico Ventures is now rolling out more widely across the university. Visit our newsroom to find out more.
Latest news and highlights
Commercialising technology since 1993
As of July 2019